Skip to main content
Log in

Diabetes

Insulin pumps after injections and CGM in T1DM

  • News & Views
  • Published:

From Nature Reviews Endocrinology

View current issue Sign up to alerts

A recent randomized controlled trial has shown that patients with type 1 diabetes mellitus who are treated with multiple daily insulin injections and continuous glucose monitoring (CGM) enjoy a further improvement in glycaemic control when switched to insulin pump therapy with CGM. However, some increase in biochemical hypoglycaemia was evident with pump treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Battelino, T. et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 55, 3155–3162 (2012).

    Article  CAS  Google Scholar 

  2. Pickup, J. C., Freeman, S. C. & Sutton, A. J. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomized controlled trials using individual patient data. BMJ 343, d3805 (2011).

    Article  Google Scholar 

  3. Beck, R. W. et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA 317, 371–378 (2017).

    Article  CAS  Google Scholar 

  4. Lind, M. et al. Continuous glucose monitoring versus conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA 317, 379–387 (2017).

    Article  CAS  Google Scholar 

  5. Beck, R. W. et al. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol. http://dx.doi.org/10.1016/S2213-8587(17)30217-6 (2017).

  6. Pickup, J. C. Insulin-pump therapy for type 1 diabetes mellitus. N. Engl. J. Med. 366, 1616–1624 (2012).

    Article  CAS  Google Scholar 

  7. Bergenstal, R. M. et al. ASPIRE In-Home Study Group. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N. Engl. J. Med. 369, 224–232 (2013).

    Article  CAS  Google Scholar 

  8. Choudhary, P. et al. Hypoglycemia prevention and user acceptance of an insulin pump system with predictive low glucose management. Diabetes Technol. Ther. 18, 288–291 (2016).

    Article  CAS  Google Scholar 

  9. Bolinder, J. et al. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomized controlled trial. Lancet 388, 2254–2263 (2016).

    Article  Google Scholar 

  10. Nixon, R., Folwell, R. & Pickup, J. C. Variations in the quality and sustainability of long-term glycaemic control with continuous subcutaneous insulin infusion. Diabet. Med. 31, 1174–1177 (2014).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John C. Pickup.

Ethics declarations

Competing interests

The author has received speaker and/or consultancy fees from Cequr, Eli Lilly, Insulet, Medtronic, Novo Nordisk and Roche.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pickup, J. Insulin pumps after injections and CGM in T1DM. Nat Rev Endocrinol 13, 568–569 (2017). https://doi.org/10.1038/nrendo.2017.108

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2017.108

  • Springer Nature Limited

Navigation